![]() |
Lung Cancer |
Free Subscription
1 Am J Surg |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Association of social vulnerability on time-to-treatment for patients with
non-small cell lung cancer.
Am J Surg. 2025;247:116481.
PubMed
Abstract available
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in
non-small cell lung cancer.
Ann Oncol. 2025 Jun 18:S0923-7534(25)00804-X. doi: 10.1016/j.annonc.2025.
PubMed
Abstract available
Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in
Stage IIIA-N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume
Center.
Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17598.
PubMed
Abstract available
Improving Lung Cancer Screening Uptake Takes a Village: The Power of Partnering
with High Catchment Hospital Departments.
Ann Thorac Surg. 2025 Jun 18:S0003-4975(25)00532.
PubMed
Comparable Clinical Outcomes Between Segmentectomy and Lobectomy for NSCLC With
Unsuspected N1/N2: A Multicenter Real-World Data Study.
Ann Thorac Surg. 2025;120:87-98.
PubMed
Abstract available
Comparison of Short- and Long-term Outcomes in Patients Undergoing Sleeve
Lobectomy With or Without Buttressing the Bronchial Anastomosis.
Ann Thorac Surg. 2025;120:100-107.
PubMed
Abstract available
Characteristics of Long-term Survivors With Malignant Pleural Mesothelioma.
Ann Thorac Surg. 2025;120:108-116.
PubMed
Abstract available
Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung
Cancer Cells.
Anticancer Res. 2025;45:3031-3044.
PubMed
Abstract available
Artogomezianone Inhibits EGFR and Promotes Apoptosis in Non-small Cell Lung
Cancer Cells.
Anticancer Res. 2025;45:2833-2845.
PubMed
Abstract available
Apigenin-induced Apoptosis in Lung Adenocarcinoma A549 Cells: Involvement in
IFNA2, TNF, and SPON2 With Different Time Points.
Anticancer Res. 2025;45:2781-2790.
PubMed
Abstract available
Development of a Benzoxazine-derived Inhibitor Targeting
Epithelial-to-Mesenchymal Transition in Lung Cancer.
Anticancer Res. 2025;45:2807-2815.
PubMed
Abstract available
Integrating Network Pharmacology and Optimization of Preparation Methods to
Enhance the Anticancer Effect of Cordyceps militaris on Lung Cancer.
Anticancer Res. 2025;45:2963-2984.
PubMed
Abstract available
Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung
Cancer.
Anticancer Res. 2025;45:3021-3029.
PubMed
Abstract available
Consensus guideline for the management of peritoneal mesothelioma.
Cancer. 2025;131:e35868.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
SECONDARY LUNG CANCER AMONG SURVIVORS OF ADOLESCENT AND YOUNG ADULT CANCER: A
POPULATION-BASED STUDY.
Cancer Epidemiol Biomarkers Prev. 2025.
PubMed
Abstract available
The significance of protein N-glycosylation in the pathogenesis of lung cancer
and its clinical implications.
Cancer Lett. 2025 Jun 25:217849. doi: 10.1016/j.canlet.2025.217849.
PubMed
Abstract available
Timing of screening benefit for lung cancer with low-dose computed tomography.
Chest. 2025 Jun 18:S0012-3692(25)00707-X. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update.
Chest. 2025 Jun 17:S0012-3692(25)00700-7. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
Management of Patients with Early-Stage Non-Small Cell Lung Cancer: An American
College of Chest Physicians Clinical Practice Guideline.
Chest. 2025 Jun 23:S0012-3692(25)00737-8. doi: 10.1016/j.chest.2025.
PubMed
Abstract available
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or
Metastatic Non-Small Cell Lung Cancer: AMBER Part 2B.
Clin Cancer Res. 2025 Jun 24:OF1-OF9. doi: 10.1158/1078-0432.CCR-25-0806.
PubMed
Abstract available
Multidimensional Analysis of B7 homolog 3 (B7-H3) RNA Expression in Small-cell
Lung Cancer Molecular Subtypes.
Clin Cancer Res. 2025 Jun 24. doi: 10.1158/1078-0432.CCR-24-3981.
PubMed
Abstract available
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib
Monotherapy in the First-Line Treatment of Patients With locally Advanced or
Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203).
Clin Lung Cancer. 2025 May 28:S1525-7304(25)00127.
PubMed
Abstract available
Predictors of Multidisciplinary Tumor Board Adherence in Stage III Non-Small-Cell
Lung Cancer Patients From a Large Multicenter Study.
Clin Lung Cancer. 2025 May 29:S1525-7304(25)00124.
PubMed
Abstract available
Clinical benefit and cost of plasma-first next-generation sequencing in patients
with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN
study.
Eur J Cancer. 2025;225:115582.
PubMed
Abstract available
Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation
Dose with Incident Heart Failure and Coronary Events in Lung Cancer Radiotherapy.
Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04493.
PubMed
Abstract available
How to Avoid Collapsing Under the Pressure of Managing Atelectasis During Lung
Cancer Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:785.
PubMed
Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for
Adaptive Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2025;122:818-826.
PubMed
Abstract available
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction
(SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
Int J Radiat Oncol Biol Phys. 2025;122:957-967.
PubMed
Abstract available
Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After
Platinum-Based Chemotherapy and Immunotherapy.
J Clin Oncol. 2025 Jun 24:JCO2402744. doi: 10.1200/JCO-24-02744.
PubMed
Abstract available
Robotic-assisted single-port system for pulmonary lobectomy: A prospective
feasibility study.
J Thorac Cardiovasc Surg. 2025;170:54-60.
PubMed
Abstract available
High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With
Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial.
JAMA Oncol. 2025 Jun 26. doi: 10.1001/jamaoncol.2025.1779.
PubMed
Abstract available
Navigating Selective Dose Intensification in EGFR-Variant Non-Small Cell Lung
Cancer.
JAMA Oncol. 2025 Jun 26. doi: 10.1001/jamaoncol.2025.1768.
PubMed
Global trends in lung cancer incidence and mortality by age, gender and
morphology and forecast: A bootstrap-based analysis.
Lung Cancer. 2025;205:108626.
PubMed
Abstract available
Bronchial washing fluid supernatant serves as a novel liquid biopsy specimen for
genome profiling in advanced non-small cell lung cancer.
Lung Cancer. 2025;205:108622.
PubMed
Abstract available
Diagnostic accuracy of the Idylla mutation test for detecting EGFR mutations in
non-small cell lung cancer: a meta-analysis.
Lung Cancer. 2025;205:108623.
PubMed
Abstract available
Combination of anlotinib and irinotecan as second-line therapy in extensive-stage
small-cell lung cancer relapsed within six months: a single-arm phase ? study.
Lung Cancer. 2025;205:108630.
PubMed
Abstract available
Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer
patients: a systematic review and meta-analysis.
Lung Cancer. 2025;205:108629.
PubMed
Abstract available
Unbridled Enthusiasm for Neoadjuvant Chemoimmunotherapy followed by Surgery for
Locally Advanced Non-Small Cell Lung Cancer.
Lung Cancer. 2025 Jun 20:108628. doi: 10.1016/j.lungcan.2025.108628.
PubMed
Burden and trends in subsequent primary lung cancer incidence by sex in the
United States.
Lung Cancer. 2025;205:108625.
PubMed
Abstract available
Four-gene Prognostic Signature and Risk of Brain Metastasis of Lung
Adenocarcinoma.
Mol Carcinog. 2025;64:1209-1221.
PubMed
Abstract available
Differential Response and Resistance to KRAS-Targeted Therapy.
Mol Carcinog. 2025;64:1135-1148.
PubMed
Abstract available
Cardiovascular adverse events in patients with lung cancer treated with immune
checkpoint inhibitors: a nationwide database study.
Oncologist. 2025;30:oyaf151.
PubMed
Abstract available
The prognostic value of sarcopenia and sarcopenic obesity in patients with lung
cancer receiving immunotherapy: a propensity score matching study.
Oncologist. 2025;30:oyaf114.
PubMed
Abstract available
Clinical utility of companion diagnostic biomarker results below the limit of
detection in comprehensive genomic profiling of patients with advanced non-small
cell lung cancer.
Oncologist. 2025;30:oyaf159.
PubMed
Abstract available
HMGB1-BoxA gene therapy in reversing cisplatin resistance in non-small cell lung
cancer.
PLoS One. 2025;20:e0327144.
PubMed
Abstract available
Does postoperative plasma IL-6 improve early prediction of infection after
pulmonary cancer surgery? A two-centre prospective study.
PLoS One. 2025;20:e0326537.
PubMed
Abstract available
Current and future applications of artificial intelligence in lung cancer and
mesothelioma.
Thorax. 2025 Jun 20:thorax-2024-222054. doi: 10.1136/thorax-2024-222054.
PubMed
Abstract available
Thank you for your interest in scientific medicine.